ArticleChina CDC weekly2025
Global Assistance and the Cascade of Malaria Prevention and Control - Sub-Saharan Africa, 2011-2022.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Approximately 70% of funding for malaria prevention and control (P&C) in Sub-Saharan Africa comes from global assistance, yet progress has stagnated over the past decade. Methods: We constructed a cascade of malaria P&C services and analyzed its coverage and quality across 26 African countries from 2011-2022. Panel analysis was conducted to examine the effectiveness of four major donors [the United States of America (USA), the United Kingdom (UK), the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF), and United Nations International Children's Emergency Fund (UNICEF)], which account for 90% of global funding, in implementing the cascade. Results: Recommended practice coverage doubled during 2011-2016 but decreased by 10% by 2022. Unrecommended practices followed the same pattern. Total funding from 2011-2020 reached 7.15 billion USA Dollar (USD), with the USA and GF steadily contributing 94.65%, while the UK and UNICEF demonstrated notable funding reductions. Overall, the funding showed limited correlation with the cascade coverage and quality, promoting directly only the upstream measures. Conclusion: Our findings highlight four key challenges: retrogression of cascade coverage since the late 2010s, persistent gaps between recommended and unrecommended practices, funding constraints, and limited direct effects of donor funding. Strengthening health system capacity at the farthest end of the cascade may provide a solution to this dilemma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.